ANIK
ANIK
NASDAQ · Biotechnology

Anika Therapeutics Inc

$20.34
-0.34 (-1.64%)
As of Sep 29, 2:50 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +17.9% upside
Low Target $18.55
Average Target $23.98
High Target $27.85
Current Price $20.34
Current
$20.34
Target
$23.98
$18.55 $23.98 avg $27.85
Scenario Analysis
Bear Case
$18.55
-8.8%
Low target
Base Case
$23.98
+17.9%
Avg target
Bull Case
$27.85
+36.9%
High target
Risk/Reward
4.2x
Highly favorable
Price in Context
52-Week High
$22.88
-11.1% from high
52-Week Low
$8.67
+134.6% from low
Target vs 52W High
$23.98
+4.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.2%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +140.7%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.6%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.8%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.2%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.5%